ABCB1 and ovarian cancer: Ascites from recurrent ovarian cancer patients following chemotherapy have been found to contain a higher percentage of side populations that overexpress ABCB1 as compared to that of chemo-naive patients [46], indicating that drug efflux system is enhanced in drug-resistant cells with stem cell characteristics.